Concepts (208)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Encephalitis Viruses, Tick-Borne | 1 | 2022 | 34 | 0.880 |
Why?
|
| Encephalitis, Tick-Borne | 1 | 2022 | 34 | 0.880 |
Why?
|
| Eye Infections, Bacterial | 4 | 2017 | 243 | 0.860 |
Why?
|
| Cornea | 7 | 2020 | 1447 | 0.740 |
Why?
|
| Encephalitis | 1 | 2022 | 440 | 0.670 |
Why?
|
| Biofilms | 3 | 2016 | 628 | 0.650 |
Why?
|
| Eye Infections, Fungal | 3 | 2020 | 112 | 0.580 |
Why?
|
| Virus Diseases | 1 | 2022 | 698 | 0.580 |
Why?
|
| Endophthalmitis | 2 | 2020 | 261 | 0.580 |
Why?
|
| Thromboembolism | 1 | 2022 | 985 | 0.560 |
Why?
|
| Vaccines | 1 | 2022 | 738 | 0.500 |
Why?
|
| Bioartificial Organs | 1 | 2014 | 62 | 0.480 |
Why?
|
| Antibiotic Prophylaxis | 2 | 2020 | 628 | 0.480 |
Why?
|
| Polyethyleneimine | 1 | 2011 | 63 | 0.420 |
Why?
|
| Prostheses and Implants | 6 | 2016 | 1345 | 0.390 |
Why?
|
| Thrombosis | 1 | 2022 | 2843 | 0.340 |
Why?
|
| Bacterial Physiological Phenomena | 1 | 2008 | 130 | 0.320 |
Why?
|
| Artificial Organs | 3 | 2016 | 200 | 0.320 |
Why?
|
| Staphylococcus aureus | 2 | 2011 | 1402 | 0.290 |
Why?
|
| Biocompatible Materials | 3 | 2013 | 1704 | 0.260 |
Why?
|
| Keratitis | 3 | 2017 | 264 | 0.250 |
Why?
|
| Epithelium, Corneal | 2 | 2016 | 254 | 0.240 |
Why?
|
| Corneal Diseases | 3 | 2016 | 596 | 0.230 |
Why?
|
| Prosthesis-Related Infections | 1 | 2008 | 510 | 0.230 |
Why?
|
| Fusarium | 2 | 2020 | 55 | 0.220 |
Why?
|
| Myelitis | 1 | 2022 | 53 | 0.210 |
Why?
|
| Guillain-Barre Syndrome | 1 | 2022 | 134 | 0.200 |
Why?
|
| Rabbits | 7 | 2017 | 5060 | 0.190 |
Why?
|
| Aspergillus fumigatus | 1 | 2020 | 150 | 0.190 |
Why?
|
| Titanium | 2 | 2013 | 487 | 0.180 |
Why?
|
| New England | 1 | 2022 | 1008 | 0.180 |
Why?
|
| Salmonella typhimurium | 5 | 1995 | 371 | 0.180 |
Why?
|
| Prosthesis Implantation | 2 | 2014 | 659 | 0.170 |
Why?
|
| Microscopy, Electron, Scanning | 3 | 2016 | 991 | 0.160 |
Why?
|
| Antifungal Agents | 2 | 2020 | 701 | 0.160 |
Why?
|
| Candida albicans | 1 | 2020 | 360 | 0.160 |
Why?
|
| Bacteria | 1 | 2008 | 2114 | 0.160 |
Why?
|
| Sanitary Engineering | 1 | 2016 | 3 | 0.160 |
Why?
|
| Genes, Bacterial | 7 | 1996 | 1136 | 0.150 |
Why?
|
| Silk | 1 | 2016 | 88 | 0.150 |
Why?
|
| Water Supply | 1 | 2016 | 208 | 0.140 |
Why?
|
| Pseudomonas Infections | 2 | 2017 | 616 | 0.140 |
Why?
|
| Contact Lenses, Hydrophilic | 2 | 2020 | 63 | 0.140 |
Why?
|
| Corneal Stroma | 1 | 2016 | 173 | 0.140 |
Why?
|
| Materials Testing | 2 | 2016 | 865 | 0.140 |
Why?
|
| Polymethyl Methacrylate | 2 | 2011 | 128 | 0.130 |
Why?
|
| Bacterial Proteins | 4 | 1996 | 3948 | 0.130 |
Why?
|
| Radiation Injuries, Experimental | 1 | 2014 | 96 | 0.120 |
Why?
|
| Phototherapy | 1 | 2017 | 338 | 0.120 |
Why?
|
| Prosthesis Coloring | 1 | 2013 | 30 | 0.120 |
Why?
|
| Anti-Bacterial Agents | 1 | 2011 | 7095 | 0.120 |
Why?
|
| Anterior Eye Segment | 1 | 2012 | 135 | 0.100 |
Why?
|
| Lipoproteins | 1 | 1996 | 914 | 0.100 |
Why?
|
| Iris | 1 | 2012 | 220 | 0.100 |
Why?
|
| Tonometry, Ocular | 1 | 2011 | 227 | 0.100 |
Why?
|
| Telemetry | 1 | 2011 | 195 | 0.100 |
Why?
|
| Durapatite | 1 | 2011 | 161 | 0.100 |
Why?
|
| Glaucoma, Angle-Closure | 1 | 2012 | 171 | 0.100 |
Why?
|
| Radio Waves | 1 | 2011 | 247 | 0.100 |
Why?
|
| Cosmetic Techniques | 1 | 2012 | 135 | 0.100 |
Why?
|
| Pseudomonas aeruginosa | 2 | 2017 | 1268 | 0.090 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2011 | 319 | 0.090 |
Why?
|
| Tissue Scaffolds | 1 | 2016 | 921 | 0.090 |
Why?
|
| Gene Expression Regulation, Bacterial | 3 | 1995 | 1154 | 0.090 |
Why?
|
| Fluorescein | 1 | 2009 | 175 | 0.090 |
Why?
|
| Uveitis | 1 | 2012 | 407 | 0.080 |
Why?
|
| Mycobacterium chelonae | 1 | 2007 | 12 | 0.080 |
Why?
|
| Retinal Diseases | 1 | 2014 | 670 | 0.080 |
Why?
|
| Light | 1 | 2014 | 1433 | 0.080 |
Why?
|
| Ciprofloxacin | 1 | 2009 | 317 | 0.080 |
Why?
|
| Intraocular Pressure | 1 | 2011 | 1165 | 0.070 |
Why?
|
| Keratomileusis, Laser In Situ | 1 | 2007 | 85 | 0.070 |
Why?
|
| Tissue Engineering | 1 | 2016 | 1829 | 0.070 |
Why?
|
| Mycobacterium tuberculosis | 1 | 1996 | 1810 | 0.070 |
Why?
|
| Fluoroquinolones | 1 | 2007 | 308 | 0.070 |
Why?
|
| Drug Resistance, Bacterial | 2 | 2016 | 1106 | 0.070 |
Why?
|
| Visual Acuity | 1 | 2014 | 2490 | 0.070 |
Why?
|
| Anti-Infective Agents | 2 | 2009 | 945 | 0.070 |
Why?
|
| Retina | 1 | 2014 | 2631 | 0.060 |
Why?
|
| Membrane Proteins | 2 | 1996 | 8047 | 0.050 |
Why?
|
| Benzalkonium Compounds | 1 | 2020 | 24 | 0.050 |
Why?
|
| Polymyxin B | 1 | 2020 | 51 | 0.050 |
Why?
|
| Trimethoprim | 1 | 2020 | 93 | 0.050 |
Why?
|
| Microbial Sensitivity Tests | 2 | 2020 | 1920 | 0.050 |
Why?
|
| Humans | 12 | 2022 | 715818 | 0.040 |
Why?
|
| Macrophages | 1 | 1993 | 5742 | 0.040 |
Why?
|
| Incidence | 2 | 2014 | 20733 | 0.040 |
Why?
|
| Animals | 10 | 2020 | 169404 | 0.040 |
Why?
|
| Surgical Wound Infection | 1 | 2007 | 1498 | 0.040 |
Why?
|
| Mycobacterium avium Complex | 1 | 2016 | 61 | 0.040 |
Why?
|
| Drug Delivery Systems | 1 | 2009 | 2210 | 0.040 |
Why?
|
| Hospitalization | 1 | 2016 | 9745 | 0.040 |
Why?
|
| Legionnaires' Disease | 1 | 2016 | 48 | 0.040 |
Why?
|
| Transformation, Bacterial | 1 | 1996 | 84 | 0.040 |
Why?
|
| Legionella pneumophila | 1 | 2016 | 47 | 0.040 |
Why?
|
| Mycobacterium avium-intracellulare Infection | 1 | 2016 | 78 | 0.040 |
Why?
|
| Swine | 2 | 2020 | 5802 | 0.040 |
Why?
|
| Transcription Factors | 2 | 1993 | 11953 | 0.040 |
Why?
|
| Colony Count, Microbial | 1 | 2017 | 342 | 0.040 |
Why?
|
| Operon | 2 | 1995 | 374 | 0.040 |
Why?
|
| Drug Combinations | 1 | 2020 | 1928 | 0.030 |
Why?
|
| DNA Transposable Elements | 2 | 1993 | 757 | 0.030 |
Why?
|
| Axons | 1 | 2022 | 1732 | 0.030 |
Why?
|
| Gene Library | 1 | 1996 | 1088 | 0.030 |
Why?
|
| Typhoid-Paratyphoid Vaccines | 1 | 1993 | 36 | 0.030 |
Why?
|
| Intraoperative Period | 1 | 2014 | 535 | 0.030 |
Why?
|
| Electrochemical Techniques | 1 | 2013 | 102 | 0.030 |
Why?
|
| Silicone Elastomers | 1 | 2012 | 88 | 0.030 |
Why?
|
| Corneal Endothelial Cell Loss | 1 | 2012 | 22 | 0.030 |
Why?
|
| Virulence | 2 | 1993 | 1338 | 0.030 |
Why?
|
| Transducers, Pressure | 1 | 2011 | 55 | 0.030 |
Why?
|
| Cells, Cultured | 3 | 2013 | 19905 | 0.030 |
Why?
|
| Risk Factors | 3 | 2014 | 70879 | 0.030 |
Why?
|
| Epithelium | 2 | 1995 | 1721 | 0.030 |
Why?
|
| Bacterial Adhesion | 1 | 1993 | 325 | 0.030 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 1 | 2011 | 160 | 0.030 |
Why?
|
| Salmonella typhi | 1 | 1993 | 174 | 0.030 |
Why?
|
| Typhoid Fever | 1 | 1993 | 164 | 0.030 |
Why?
|
| Shear Strength | 1 | 2011 | 159 | 0.030 |
Why?
|
| Spectrometry, X-Ray Emission | 1 | 2011 | 148 | 0.030 |
Why?
|
| Retrospective Studies | 3 | 2016 | 72473 | 0.030 |
Why?
|
| Endothelium, Corneal | 1 | 2013 | 188 | 0.030 |
Why?
|
| Transducers | 1 | 2011 | 247 | 0.020 |
Why?
|
| Natamycin | 1 | 2009 | 5 | 0.020 |
Why?
|
| United States | 2 | 2016 | 67910 | 0.020 |
Why?
|
| Fluorescein Angiography | 1 | 2014 | 890 | 0.020 |
Why?
|
| Alternaria | 1 | 2009 | 48 | 0.020 |
Why?
|
| Polyhydroxyethyl Methacrylate | 1 | 2009 | 30 | 0.020 |
Why?
|
| Amphotericin B | 1 | 2009 | 142 | 0.020 |
Why?
|
| Mutagenesis | 1 | 1993 | 1281 | 0.020 |
Why?
|
| Microscopy | 1 | 2014 | 862 | 0.020 |
Why?
|
| Surface Properties | 1 | 2011 | 1177 | 0.020 |
Why?
|
| Cell Count | 1 | 2012 | 1912 | 0.020 |
Why?
|
| Contact Lenses | 1 | 2009 | 145 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1996 | 3844 | 0.020 |
Why?
|
| beta-Lactamases | 1 | 1990 | 372 | 0.020 |
Why?
|
| Genetic Linkage | 1 | 1993 | 2508 | 0.020 |
Why?
|
| Administration, Topical | 1 | 2009 | 700 | 0.020 |
Why?
|
| Polyglycolic Acid | 1 | 2009 | 420 | 0.020 |
Why?
|
| Clarithromycin | 1 | 2007 | 79 | 0.020 |
Why?
|
| Device Removal | 1 | 2012 | 649 | 0.020 |
Why?
|
| Candidiasis | 1 | 2009 | 360 | 0.020 |
Why?
|
| Repressor Proteins | 2 | 1995 | 3063 | 0.020 |
Why?
|
| Cell Membrane | 1 | 1996 | 3881 | 0.020 |
Why?
|
| Escherichia coli | 2 | 1996 | 4277 | 0.020 |
Why?
|
| Cell Proliferation | 2 | 2013 | 10615 | 0.020 |
Why?
|
| Chromosome Mapping | 2 | 1993 | 4823 | 0.020 |
Why?
|
| Corneal Transplantation | 1 | 2009 | 371 | 0.020 |
Why?
|
| Administration, Oral | 2 | 2009 | 3955 | 0.020 |
Why?
|
| Myopia | 1 | 2007 | 250 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 1993 | 6641 | 0.020 |
Why?
|
| Lactic Acid | 1 | 2009 | 1118 | 0.020 |
Why?
|
| Adult | 5 | 2022 | 212279 | 0.010 |
Why?
|
| Alkylating Agents | 1 | 1983 | 133 | 0.010 |
Why?
|
| Mutagens | 1 | 1983 | 176 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2013 | 4228 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 1993 | 6009 | 0.010 |
Why?
|
| Female | 5 | 2022 | 377229 | 0.010 |
Why?
|
| Male | 5 | 2022 | 350352 | 0.010 |
Why?
|
| Mice | 3 | 2017 | 80373 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2009 | 6552 | 0.010 |
Why?
|
| Genotype | 1 | 1993 | 12919 | 0.010 |
Why?
|
| Cell Line | 1 | 1993 | 16575 | 0.010 |
Why?
|
| Surgical Flaps | 1 | 2007 | 1634 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2017 | 22663 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2022 | 51317 | 0.010 |
Why?
|
| Aged | 3 | 2016 | 162468 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 18197 | 0.010 |
Why?
|
| Cloning, Molecular | 2 | 1995 | 4439 | 0.010 |
Why?
|
| Boston | 1 | 2009 | 9377 | 0.010 |
Why?
|
| Young Adult | 1 | 2022 | 56228 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2017 | 39305 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 1995 | 908 | 0.010 |
Why?
|
| Adolescent | 1 | 2022 | 85157 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2011 | 19537 | 0.010 |
Why?
|
| RNA, Bacterial | 1 | 1995 | 395 | 0.010 |
Why?
|
| 4-Nitroquinoline-1-oxide | 2 | 1983 | 18 | 0.010 |
Why?
|
| Methyl Methanesulfonate | 2 | 1983 | 34 | 0.010 |
Why?
|
| Ethyl Methanesulfonate | 2 | 1983 | 30 | 0.010 |
Why?
|
| Middle Aged | 2 | 2022 | 214666 | 0.010 |
Why?
|
| Genes, Regulator | 1 | 1993 | 392 | 0.010 |
Why?
|
| Vaccines, Attenuated | 1 | 1993 | 330 | 0.010 |
Why?
|
| Base Sequence | 2 | 1995 | 13179 | 0.010 |
Why?
|
| Isoelectric Focusing | 1 | 1990 | 212 | 0.010 |
Why?
|
| Mutation | 3 | 1993 | 29290 | 0.010 |
Why?
|
| Endocytosis | 1 | 1995 | 1006 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1995 | 2913 | 0.010 |
Why?
|
| Amino Acid Sequence | 2 | 1995 | 14161 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2016 | 58326 | 0.010 |
Why?
|
| Molecular Sequence Data | 2 | 1995 | 18591 | 0.010 |
Why?
|
| DNA Probes | 1 | 1990 | 571 | 0.010 |
Why?
|
| Species Specificity | 1 | 1993 | 2599 | 0.010 |
Why?
|
| Child | 1 | 2016 | 74468 | 0.010 |
Why?
|
| Ultraviolet Rays | 2 | 1983 | 1069 | 0.000 |
Why?
|
| Cohort Studies | 1 | 2009 | 40032 | 0.000 |
Why?
|
| Methylnitronitrosoguanidine | 1 | 1983 | 22 | 0.000 |
Why?
|
| Sequence Analysis, DNA | 1 | 1995 | 4918 | 0.000 |
Why?
|
| Methylnitrosourea | 1 | 1983 | 31 | 0.000 |
Why?
|
| Epithelial Cells | 1 | 1995 | 3636 | 0.000 |
Why?
|
| Genetic Vectors | 1 | 1993 | 3529 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 2009 | 62040 | 0.000 |
Why?
|
| Kinetics | 1 | 1990 | 6654 | 0.000 |
Why?
|
| Transcription, Genetic | 1 | 1995 | 7885 | 0.000 |
Why?
|
| Chromosomes, Bacterial | 1 | 1981 | 303 | 0.000 |
Why?
|
| RNA, Messenger | 1 | 1995 | 13212 | 0.000 |
Why?
|
| Recombination, Genetic | 1 | 1983 | 1692 | 0.000 |
Why?
|
| DNA Repair | 1 | 1983 | 2034 | 0.000 |
Why?
|
| Models, Genetic | 1 | 1983 | 3516 | 0.000 |
Why?
|
Concepts
(208)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(25)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_